NCT07428889

Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

A Randomized, Controlled, Pilot Trial to Assess the Effects of a Proprietary Nutritional Supplement on Nicotinamide Adenine Dinucleotide (NAD+) Responses in Healthy Adults

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 34 (estimated)
• Sponsor: Shaklee Corporation · Industry
• Sex: All
• Age: 45 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.

Detailed description

The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+), its metabolites, and markers of health in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.

Conditions

• Healthy Adult

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Proprietary Nutritional Supplement	1000 mg nicotinamide metabolites and plant extracts, taken orally, daily for 60 days
DIETARY_SUPPLEMENT	Placebo Supplement	1000 mg maltodextrin, taken orally, daily for 60 days

Timeline

• Start date: 2026-02-17
• Primary completion: 2026-06-01
• Completion: 2026-06-01
• First posted: 2026-02-24
• Last updated: 2026-04-13

Locations

1 site across 1 country: United States